I am sorry to miss the JC for travel reasons. I hope participants will read our JAMA article, which is not primarily asking the question “Do eGFR equations insidiously lead to discrimination on the basis of race?”#nephJC #AmakaEMD
— Peter P. Reese (@PeterPReese1) August 6, 2019
Instead, the article identifies problems of imprecision and non-transparency with using race in eGFR. We list plausible positive and negative consequences of using race, such as clinical trial participation and transplant referral. #nephJC #AmakaEMD
— Peter P. Reese (@PeterPReese1) August 6, 2019
Finally, we ask whether equivalent precision in GFR estimation could be achieved by substituting other commonly available variables for race and ... why did it take over a decade for our field to ask that question? #nephJC #AmakaEMD
— Peter P. Reese (@PeterPReese1) August 6, 2019
Using race to tailor clinical care is justified only if:1) that use confers substantial benefit; 2) the benefit cannot be achieved through other feasible approaches; 3) patients who refuse race categorization are accommodated fairly; and 4) the use of race is transparent. #nephjc
— Peter P. Reese (@PeterPReese1) August 6, 2019